Paul Knight Analyst Performance

Paul Knight is a stock analyst at KeyCorp focused in the medical sector, covering 24 publicly traded companies. Over the past year, Paul Knight has issued 14 stock ratings, including buy and hold recommendations. While full access to Paul Knight's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Paul Knight's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

37 Last 9 Years

Buy Recommendations

72.97% 27 Buy Ratings

Companies Covered

24 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	73.0%	27 ratings
Hold	24.3%	9 ratings
Sell	2.7%	1 ratings

Out of 37 total stock ratings issued by Paul Knight at KeyCorp, the majority (73.0%) have been Buy recommendations, followed by 24.3% Hold and 2.7% Sell.

Best & Worst Calls

• Best Call

  000.0%

  BLFS

  Dec 2018

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  TTOO

  May 2018

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	58.3% of companies on NASDAQ	14 companies
NYSE	41.7% of companies on NYSE	10 companies

Paul Knight, an analyst at KeyCorp, currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 18 companies	75.0%
	Computer and Technology 2 companies	8.3%
	Industrials 1 company	4.2%
	Transportation 1 company	4.2%
	Consumer Discretionary 1 company	4.2%
	Retail/Wholesale 1 company	4.2%

Paul Knight of KeyCorp specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Industrials companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 4 companies	16.7%
MED PRODUCTS 4 companies	16.7%
MED INSTRUMENTS 3 companies	12.5%
CONTNRS - PPR/PLS 1 company	4.2%
TRANS - SERVICES 1 company	4.2%
MED - OUTP/HM CRE 1 company	4.2%
INSTRU - SCIENTFC 1 company	4.2%
MEDICAL INFO SYS 1 company	4.2%
MED/DENTAL - SUPP 1 company	4.2%
MEDICAL SERVICES 1 company	4.2%
TEXTILE - APPAREL 1 company	4.2%
RETAIL - APP/SHOE 1 company	4.2%
SPECIAL INDUSTRY MACHINERY 1 company	4.2%
MED - DRUGS 1 company	4.2%
PHARMACEUTICAL PREPARATIONS 1 company	4.2%
SURGICAL & MEDICAL INSTRUMENTS 1 company	4.2%

Paul Knight's Ratings History at KeyCorp

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
ATR AptarGroup	9/3/2025	Initiated Coverage	$135.07	$220.00	Overweight	$0.00 00.00% ROI
LFCR Lifecore Biomedical	9/3/2025	Initiated Coverage	$7.71		Sector Weight	$0.00 00.00% ROI
CYRX CryoPort	8/6/2025	Upgrade	$6.74	$15.00	Overweight	$0.00 00.00% ROI
XGN Exagen	7/30/2025	Upgrade	$8.45	$12.00	Overweight	$0.00 00.00% ROI
EHC Encompass Health	5/27/2025	Boost Price Target	$118.74	$135.00	Overweight	$0.00 00.00% ROI
HBIO Harvard Bioscience	4/9/2025	Reiterated Rating	$0.37		Sector Weight	$0.00 00.00% ROI
TECH Bio-Techne	4/9/2025	Reiterated Rating	$48.81		Sector Weight	$0.00 00.00% ROI
WAT Waters	3/31/2025	Upgrade	$361.61	$460.00	Overweight	$0.00 00.00% ROI
LAB Standard BioTools	2/27/2025	Downgrade	$1.17		Sector Weight	$0.00 00.00% ROI
WST West Pharmaceutical Services	2/14/2025	Lower Price Target	$221.90	$325.00	Overweight	$0.00 00.00% ROI
RPID Rapid Micro Biosystems	2/12/2025	Initiated Coverage	$2.68	$8.00	Overweight	$0.00 00.00% ROI
RVTY Revvity	2/3/2025	Boost Price Target	$126.13	$145.00	Overweight	$0.00 00.00% ROI
LULU lululemon athletica	1/23/2025	Boost Price Target	$382.82	$420.00	Overweight	$0.00 00.00% ROI
DECK Deckers Outdoor	1/23/2025	Boost Price Target	$215.04	$230.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.